Advanced Enzyme Technologies repurchases 1.11 lakh shares on August 14
AI Market Summary
Advanced Enzyme Technologies started its board-approved open-market buyback, repurchasing 110,951 shares at an average ₹303.80 versus a ₹500 cap, within a program for up to 1.394m shares (1.24% of capital) and ₹697m. The action signals capital return capacity and management confidence, but the scale is modest and largely idiosyncratic, limiting broader market spillover despite mixed Q1 profitability and margin compression.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT+0.26%
AI Insight · NCCOGOLD2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Advanced Enzyme Technologies repurchased 1.11 lakh shares on August 14. The purchases were made under a previously announced open-market buyback plan. The plan allows the company to buy back up to 13.94 lakh shares, or about 1.24% of its total equity, for up to ₹697 million at a maximum price of ₹500 per share. The buyback will be funded through free reserves and internal accruals.
